GLA, galactosidase alpha, 2717

N. diseases: 190; N. variants: 203
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.120 Biomarker disease HPO
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.120 Biomarker disease BEFREE Fabry disease is a disorder of glycosphingolipid metabolism caused by deficiency of lysosomal alpha-galactosidase A (alpha-Gal A), resulting in renal failure along with premature myocardial infarction and strokes. 9883849 1999
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.120 Biomarker disease BEFREE In addition to well-described microvascular disease, deficiency of GLA is also characterized by premature macrovascular events such as stroke and possibly myocardial infarction. 17482095 2007